Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $6.20 Analyst target: $18.71 Upside: 201.77%
Solid Biosciences Inc., a life sciences company, is dedicated to developing therapies for Duchenne muscular dystrophy (DMD) in the United States. The company is headquartered in Cambridge, Massachusetts.
See the full interactive analysis & chart →Informational only — not investment advice.